Philips Strengthens Collaboration with Leading Medical and Academic Institutions to Innovate in Personalized Health Solutions
December 06 2016 - 8:05AM
Business Wire
Co-locates Philips Intellispace Genomics R&D team within New
York Medical College to advance solution for Precision Medicine for
Cancer Treatment
Royal Philips (NYSE:PHG, AEX:PHIA) today announced that it is
co-locating researchers from its Philips Intellispace Genomics team
with New York Medical College (NYMC), one of the oldest and largest
health sciences universities in the country, and a long-standing
collaborator in the creation of the Philips IntelliSpace solution
for oncology genomics. Located in Westchester, New York, the
Philips team will be sharing space at the NYMC new biotechnology
incubator, BioInc@NYMC and working on collaborative computational
genomics of large data sets. This not only supports Philips work in
personalized cancer care, but it also builds on Philips Research
North America’s efforts to cross-pollinate with leading academic
institutions, helping to develop innovations that can address
society’s most pressing healthcare challenges and deliver on the
company’s vision of improving the lives of three billion people by
2025.
Philips’ IntelliSpace Genomics is a configurable, scalable and
secure healthcare informatics solution across hospitals for
delivering real-time, actionable diagnostic information to
physicians and specialists for therapy planning at the point of
care. Philips IntelliSpace Genomics’ collaborative solution enables
physicians to answer key clinical questions by leveraging the best
clinical expertise and algorithmic power in integrated workflows.
It seamlessly brings data from multiple sources, including raw
sequencing data, up-to-date in silico genomic databases, clinical
data and knowledge databases, longitudinal patient records, medical
images and pathology data, among others.
“Bringing on Phillips Healthcare Research as the anchor tenant
at BioInc@NYMC is a true game changer – for the college,
Westchester County and beyond. The positioning of nine innovative
companies alongside such a notable name in healthcare research will
add to the already impressive track record of our start-ups and the
medical solutions they develop,” said Randi D. Schwartz, M.B.A.,
Director of BioInc@NYMC and Associate Dean for academic
administration.
"BioInc@NYMC is a thriving member of both the Westchester and
the greater New York innovation ecosystem. We are excited to
announce Phillips Healthcare Research as our biotech/high-tech
incubator's new anchor tenant. The computational genomics
collaboration between NYMC and Philips promises both research and
economic benefits. Philips Healthcare Research and BioInc@NYMC's
other clients are working every day to develop novel technologies
and healthcare solutions," said D. Douglas Miller, M.D., C.M.,
M.B.A., Dean of the School of Medicine at New York Medical College,
Vice-Provost for Biomedical Affairs and Chief Scientific Officer of
BioInc@NYMC.
Working from space on the NYMC campus allows Philips to
collaborate more closely with its innovation partners at the
College and their three affiliated teaching hospitals on the
Valhalla, New York campus of Westchester Medical Center Health
Network (WMCHealth). WMCHealth has also launched a new precision
medicine initiative for personalized cancer treatment, which will
leverage Philips’ IntelliSpace Genomics solution as one of the
first partners to integrate large-scale genomic analysis with
extensive patient clinical data.
“In order to create technologies that can have a meaningful
impact on human health and enable us to focus on building a healthy
society, we need to work closely with leading healthcare
institutions to co-create outcome-based solutions,” said Hans-Aloys
Wischmann, Head of Philips Research Americas. “No single company
will be able to create the solutions needed, it will take
collaborative efforts, and we believe that working with academic
institutions like New York Medical College will provide tremendous
opportunities to shape a totally new approach to the delivery of
healthcare.”
About Royal Philips
Royal Philips (NYSE:PHG, AEX:PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips' health
technology portfolio generated 2015 sales of EUR 16.8 billion and
employs approximately 70,000 employees with sales and services in
more than 100 countries. News about Philips can be found
at www.philips.com/newscenter.
About New York Medical College
Founded in 1860, NYMC is one of the oldest and largest health
sciences colleges in the country with more than 1,400 students,
1,300 residents and clinical fellows, nearly 3,000 faculty members,
and 16,000 living alumni. The College, which joined the Touro
College and University System in 2011, is located in Westchester
County, New York, and offers advanced degrees from the School of
Medicine, the Graduate School of Basic Medical Sciences, and the
School of Health Sciences and Practice. With a network of
affiliated hospitals that includes large urban medical centers,
small suburban clinics and high-tech regional tertiary care
facilities, NYMC provides a wide variety of clinical training
opportunities throughout the tri-state region for medical students,
residents, and other health providers.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161206005818/en/
Philips North AmericaSilvie Casanova,
978-657-7467silvie.casanova@philips.com
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Apr 2023 to Apr 2024